FDA names seven companies to its PreCheck pilot to speed U.S. drug manufacturing reviews after receiving more than 80 applications.

Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC has learned.

Biopharma giants Eli Lilly and Regeneron and rapidly growing contract manufacturers Fujifilm and Cellares are among the seven companies

FDA names seven companies to its PreCheck pilot to speed U.S. drug manufacturing reviews after receiving more than 80 applications.

FDA picks Eli Lilly, Regeneron, Fujifilm, Cellares, Amneal, Kriya and Kyowa Kirin for its PreCheck pilot to speed US manufacturing reviews ahead of drug approvals.